Scientists map cancer genes to find the right experimental drugs
NCT ID NCT04510766
Summary
This study aims to understand the genetic makeup of advanced cancers to help match patients with the most suitable early-stage drug trials. It involves analyzing tumor tissue and blood samples from about 40 adults with advanced solid tumors or lymphoma. The goal is to learn if detailed genetic information can improve how patients are selected for new experimental treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oncology Institute of Southern Switzerland
RECRUITINGBellinzona, 6500, Switzerland
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.